molecular drivers and therapeutic targets for neuroendocrine transformation in lung cancer
Published 2 years ago • 189 plays • Length 3:33Download video MP4
Download video MP3
Similar videos
-
0:58
how molecular therapeutics have changed the role of radiology in lung cancer care
-
1:15
dll3, a new biomarker for neuroendocrine tumors of the lung
-
2:07
molecular classification of pulmonary carcinoid and large cell nets
-
2:31
transformed sclc: emerging science on histologic subtype switching
-
5:21
molecular testing and actionable targets in lung cancer
-
9:30
lineage plasticity in lung cancer: biological & therapeutic implications
-
1:07
challenges faced in the management of brain metastases and large cell neuroendocrine lung cancers
-
2:03
key challenges in treating carcinoid and large cell neuroendocrine tumors
-
11:15
lung neuroendocrine tumors (sukhmani padda, md)
-
2:07
the role of surgery in treating neuroendocrine cancer
-
51:17
different tests different drivers: the power of collaboration to solve a molecular mystery
-
3:27
emerging molecular targets for advanced non small cell lung cancer nsclc
-
3:04
irinotecan/cisplatin vs etoposide/cisplatin in resected high-grade neuroendocrine lung carcinoma
-
1:16
dr. socinski on recommendations for molecular testing in lung cancer
-
2:32
neuroendocrine tumors: next steps in research
-
32:12
radiology and lung neuroendocrine tumours
-
10:01
'lung diagnosis & investigations' - a talk by professor martyn caplin
-
0:58
novel immunotherapeutic strategies in lung cancer
-
0:54
dr. comperat on the treatment strategy for neuroendocrine tumors